152 related articles for article (PubMed ID: 25781684)
1. Fascin is a circulating tumor marker for head and neck cancer as determined by a proteomic analysis of interstitial fluid from the tumor microenvironment.
Lee LY; Chen YJ; Lu YC; Liao CT; Chen IH; Chang JT; Huang YC; Chen WH; Huang CC; Tsai CY; Cheng AJ
Clin Chem Lab Med; 2015 Sep; 53(10):1631-41. PubMed ID: 25781684
[TBL] [Abstract][Full Text] [Related]
2. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
4. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.
Sun W; Xing B; Guo L; Liu Z; Mu J; Sun L; Wei H; Zhao X; Qian X; Jiang Y; He F
Sci Rep; 2016 May; 6():26499. PubMed ID: 27216119
[TBL] [Abstract][Full Text] [Related]
6. Fascin expression is increased in metastatic lesions but does not correlate with progression nor outcome in melanoma.
Ma Y; Faller WJ; Sansom OJ; Brown ER; Doig TN; Melton DW; Machesky LM
Melanoma Res; 2015 Apr; 25(2):169-72. PubMed ID: 25535872
[TBL] [Abstract][Full Text] [Related]
7. Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.
Tan VY; Lewis SJ; Adams JC; Martin RM
BMC Med; 2013 Feb; 11():52. PubMed ID: 23442983
[TBL] [Abstract][Full Text] [Related]
8. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.
Zhang J; Hao N; Liu W; Lu M; Sun L; Chen N; Wu M; Zhao X; Xing B; Sun W; He F
Br J Cancer; 2017 Nov; 117(11):1676-1684. PubMed ID: 29024941
[TBL] [Abstract][Full Text] [Related]
9. Combination Strategy of Quantitative Proteomics Uncovers the Related Proteins of Colorectal Cancer in the Interstitial Fluid of Colonic Tissue from the AOM-DSS Mouse Model.
Hou G; Wang Y; Lou X; Liu S
Methods Mol Biol; 2018; 1788():185-192. PubMed ID: 29139078
[TBL] [Abstract][Full Text] [Related]
10. The prognostic relevance of fascin expression in human gastric carcinoma.
Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
[TBL] [Abstract][Full Text] [Related]
11. Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Pyo JS; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J; Moon KM
Virchows Arch; 2016 Apr; 468(4):409-16. PubMed ID: 26719157
[TBL] [Abstract][Full Text] [Related]
12. Serological investigation of the clinical significance of fascin in non-small-cell lung cancer.
Teng Y; Xu S; Yue W; Ma L; Zhang L; Zhao X; Guo Y; Zhang C; Gu M; Wang Y
Lung Cancer; 2013 Nov; 82(2):346-52. PubMed ID: 24070574
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
14. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
15. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
16. [Expression and diagnosis value of Fascin in non-small cell lung cancer patients].
Liu YG; Gao XD; Yue WT
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2505-7. PubMed ID: 24300277
[TBL] [Abstract][Full Text] [Related]
17. Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma.
Stewart CJ; Crook ML
Hum Pathol; 2015 Oct; 46(10):1514-20. PubMed ID: 26239622
[TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
Teng PN; Hood BL; Sun M; Dhir R; Conrads TP
J Proteome Res; 2011 Mar; 10(3):1333-42. PubMed ID: 21142074
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
20. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
